• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

肿瘤外微环境中的基因表达可预测乳腺癌患者的临床结局。

Gene expression in extratumoral microenvironment predicts clinical outcome in breast cancer patients.

机构信息

Department of Epidemiology, University of North Carolina at Chapel Hill, Campus Box 7435, Chapel Hill, NC 27599, USA.

出版信息

Breast Cancer Res. 2012 Mar 19;14(2):R51. doi: 10.1186/bcr3152.

DOI:10.1186/bcr3152
PMID:22429463
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC3446385/
Abstract

INTRODUCTION

A gene expression signature indicative of activated wound responses is common to more than 90% of non-neoplastic tissues adjacent to breast cancer, but these tissues also exhibit substantial heterogeneity. We hypothesized that gene expression subtypes of breast cancer microenvironment can be defined and that these microenvironment subtypes have clinical relevance.

METHODS

Gene expression was evaluated in 72 patient-derived breast tissue samples adjacent to invasive breast cancer or ductal carcinoma in situ. Unsupervised clustering identified two distinct gene expression subgroups that differed in expression of genes involved in activation of fibrosis, cellular movement, cell adhesion and cell-cell contact. We evaluated the prognostic relevance of extratumoral subtype (comparing the Active group, defined by high expression of fibrosis and cellular movement genes, to the Inactive group, defined by high expression of claudins and other cellular adhesion and cell-cell contact genes) using clinical data. To establish the biological characteristics of these subtypes, gene expression profiles were compared against published and novel tumor and tumor stroma-derived signatures (Twist-related protein 1 (TWIST1) overexpression, transforming growth factor beta (TGF-β)-induced fibroblast activation, breast fibrosis, claudin-low tumor subtype and estrogen response). Histological and immunohistochemical analyses of tissues representing each microenvironment subtype were performed to evaluate protein expression and compositional differences between microenvironment subtypes.

RESULTS

Extratumoral Active versus Inactive subtypes were not significantly associated with overall survival among all patients (hazard ratio (HR) = 1.4, 95% CI 0.6 to 2.8, P = 0.337), but there was a strong association with overall survival among estrogen receptor (ER) positive patients (HR = 2.5, 95% CI 0.9 to 6.7, P = 0.062) and hormone-treated patients (HR = 2.6, 95% CI 1.0 to 7.0, P = 0.045). The Active subtype of breast microenvironment is correlated with TWIST-overexpression signatures and shares features of claudin-low breast cancers. The Active subtype was also associated with expression of TGF-β induced fibroblast activation signatures, but there was no significant association between Active/Inactive microenvironment and desmoid type fibrosis or estrogen response gene expression signatures. Consistent with the RNA expression profiles, Active cancer-adjacent tissues exhibited higher density of TWIST nuclear staining, predominantly in epithelium, and no evidence of increased fibrosis.

CONCLUSIONS

These results document the presence of two distinct subtypes of microenvironment, with Active versus Inactive cancer-adjacent extratumoral microenvironment influencing the aggressiveness and outcome of ER-positive human breast cancers.

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/101e/3446385/379a282450c8/bcr3152-2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/101e/3446385/e8f4f69ba50c/bcr3152-1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/101e/3446385/379a282450c8/bcr3152-2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/101e/3446385/e8f4f69ba50c/bcr3152-1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/101e/3446385/379a282450c8/bcr3152-2.jpg
摘要

简介

在超过 90%的乳腺癌旁非肿瘤组织中,存在一种能指示激活的伤口反应的基因表达特征,但这些组织也表现出明显的异质性。我们假设可以定义乳腺癌微环境的基因表达亚型,并且这些微环境亚型具有临床相关性。

方法

对 72 例来自浸润性乳腺癌或导管原位癌患者的乳腺组织样本进行基因表达评估。无监督聚类确定了两个不同的基因表达亚组,这些亚组在参与纤维化、细胞运动、细胞黏附和细胞-细胞接触激活的基因表达上存在差异。我们使用临床数据评估了肿瘤外亚型(将高表达纤维化和细胞运动基因的“活跃”组与高表达紧密连接和其他细胞黏附和细胞-细胞接触基因的“不活跃”组进行比较)的预后相关性。为了确定这些亚型的生物学特征,我们将基因表达谱与已发表和新的肿瘤和肿瘤基质衍生的特征(TWIST 相关蛋白 1(TWIST1)过表达、转化生长因子β(TGF-β)诱导的成纤维细胞激活、乳腺纤维化、claudin-low 肿瘤亚型和雌激素反应)进行了比较。对代表每种微环境亚型的组织进行了组织学和免疫组织化学分析,以评估微环境亚型之间的蛋白表达和组成差异。

结果

在所有患者中,肿瘤旁活跃与不活跃亚组与总生存无显著相关性(危险比(HR)=1.4,95%CI 0.6 至 2.8,P=0.337),但在雌激素受体(ER)阳性患者(HR=2.5,95%CI 0.9 至 6.7,P=0.062)和激素治疗患者(HR=2.6,95%CI 1.0 至 7.0,P=0.045)中与总生存有很强的相关性。乳腺癌微环境的活跃亚型与 TWIST 过表达特征相关,并具有 claudin-low 乳腺癌的特征。活跃亚型也与 TGF-β 诱导的成纤维细胞激活特征表达相关,但活跃/不活跃微环境与纤维瘤样纤维化或雌激素反应基因表达特征之间无显著相关性。与 RNA 表达谱一致,活跃的癌旁组织显示 TWIST 核染色密度较高,主要位于上皮细胞,且无纤维化增加的证据。

结论

这些结果证明存在两种不同的微环境亚型,活跃与不活跃的肿瘤旁肿瘤外微环境影响 ER 阳性人乳腺癌的侵袭性和结局。

相似文献

1
Gene expression in extratumoral microenvironment predicts clinical outcome in breast cancer patients.肿瘤外微环境中的基因表达可预测乳腺癌患者的临床结局。
Breast Cancer Res. 2012 Mar 19;14(2):R51. doi: 10.1186/bcr3152.
2
High TWIST1 mRNA expression is associated with poor prognosis in lymph node-negative and estrogen receptor-positive human breast cancer and is co-expressed with stromal as well as ECM related genes.TWIST1 mRNA高表达与淋巴结阴性且雌激素受体阳性的人类乳腺癌预后不良相关,并与基质及细胞外基质相关基因共表达。
Breast Cancer Res. 2012 Sep 11;14(5):R123. doi: 10.1186/bcr3317.
3
ARTEMIN synergizes with TWIST1 to promote metastasis and poor survival outcome in patients with ER negative mammary carcinoma.ARTEMIN 与 TWIST1 协同作用,促进 ER 阴性乳腺癌患者的转移和不良预后。
Breast Cancer Res. 2011;13(6):R112. doi: 10.1186/bcr3054. Epub 2011 Nov 7.
4
JNK1 stress signaling is hyper-activated in high breast density and the tumor stroma: connecting fibrosis, inflammation, and stemness for cancer prevention.JNK1应激信号在乳腺密度高和肿瘤基质中过度激活:将纤维化、炎症和干性联系起来以预防癌症。
Cell Cycle. 2014;13(4):580-99. doi: 10.4161/cc.27379. Epub 2013 Dec 5.
5
Relationship of mammographic density and gene expression: analysis of normal breast tissue surrounding breast cancer.乳腺癌周围正常乳腺组织的钼靶密度与基因表达的关系分析。
Clin Cancer Res. 2013 Sep 15;19(18):4972-4982. doi: 10.1158/1078-0432.CCR-13-0029. Epub 2013 Aug 5.
6
A triple hormone receptor ER, AR, and VDR signature is a robust prognosis predictor in breast cancer.三重激素受体 ER、AR 和 VDR 标志物是乳腺癌强有力的预后预测指标。
Breast Cancer Res. 2024 Sep 13;26(1):132. doi: 10.1186/s13058-024-01876-9.
7
Analysis of stromal signatures in the tumor microenvironment of ductal carcinoma in situ.分析导管原位癌肿瘤微环境中的基质特征。
Breast Cancer Res Treat. 2010 Sep;123(2):397-404. doi: 10.1007/s10549-009-0654-0. Epub 2009 Dec 1.
8
Expression and significance of Twist, estrogen receptor, and E-cadherin in human breast cancer cells and tissues.Twist、雌激素受体和E-钙黏蛋白在人乳腺癌细胞及组织中的表达及意义
J Cancer Res Ther. 2017;13(4):707-714. doi: 10.4103/jcrt.JCRT_1396_16.
9
Over-Expressed Twist Associates with Markers of Epithelial Mesenchymal Transition and Predicts Poor Prognosis in Breast Cancers via ERK and Akt Activation.过表达的Twist与上皮-间质转化标志物相关,并通过激活ERK和Akt预测乳腺癌的不良预后。
PLoS One. 2015 Aug 21;10(8):e0135851. doi: 10.1371/journal.pone.0135851. eCollection 2015.
10
ColXα1 is a stromal component that colocalizes with elastin in the breast tumor extracellular matrix.ColXα1 是一种基质成分,与弹性蛋白在乳腺肿瘤细胞外基质中共定位。
J Pathol Clin Res. 2019 Jan;5(1):40-52. doi: 10.1002/cjp2.115. Epub 2018 Nov 1.

引用本文的文献

1
Atorvastatin lowers breast cancer risk by reversing an early tumorigenic signature.阿托伐他汀通过逆转早期致癌特征降低乳腺癌风险。
Sci Rep. 2024 Aug 1;14(1):17803. doi: 10.1038/s41598-024-67706-2.
2
Targeting the Tumor Microenvironment in Breast Cancer: Prognostic and Predictive Significance and Therapeutic Opportunities.靶向乳腺癌肿瘤微环境:预后和预测意义及治疗机会。
Int J Mol Sci. 2023 Nov 26;24(23):16771. doi: 10.3390/ijms242316771.
3
Adipose-enriched peri-tumoral stroma, in contrast to myofibroblast-enriched stroma, prognosticates poorer survival in breast cancers.

本文引用的文献

1
Gene expression profiles of breast biopsies from healthy women identify a group with claudin-low features.健康女性乳腺活检的基因表达谱鉴定出具有 Claudin-low 特征的一类人群。
BMC Med Genomics. 2011 Nov 1;4:77. doi: 10.1186/1755-8794-4-77.
2
Artificially induced epithelial-mesenchymal transition in surgical subjects: its implications in clinical and basic cancer research.外科手术中人为诱导的上皮-间充质转化:其在临床和基础癌症研究中的意义。
PLoS One. 2011 Apr 21;6(4):e18196. doi: 10.1371/journal.pone.0018196.
3
Why don't we get more cancer? A proposed role of the microenvironment in restraining cancer progression.
与富含肌成纤维细胞的基质相比,富含脂肪的肿瘤周围基质预示着乳腺癌患者的生存率更低。
NPJ Breast Cancer. 2023 Oct 20;9(1):84. doi: 10.1038/s41523-023-00590-7.
4
Fibroblasts as Turned Agents in Cancer Progression.成纤维细胞作为癌症进展中的转化因子。
Cancers (Basel). 2023 Mar 28;15(7):2014. doi: 10.3390/cancers15072014.
5
Plant extract from inhibits cancer-associated fibroblast-like cells generation and function in a tumor microenvironment model.来自[具体植物名称未给出]的植物提取物在肿瘤微环境模型中抑制癌症相关成纤维细胞样细胞的生成和功能。
Heliyon. 2023 Mar 2;9(3):e14148. doi: 10.1016/j.heliyon.2023.e14148. eCollection 2023 Mar.
6
Resistance of MMTV-NeuT/ATTAC mice to anti-PD-1 immune checkpoint therapy is associated with macrophage infiltration and Wnt pathway expression.MMTV-NeuT/ATTAC 小鼠对抗 PD-1 免疫检查点治疗的耐药性与巨噬细胞浸润和 Wnt 通路表达有关。
Oncotarget. 2022 Dec 20;13:1350-1358. doi: 10.18632/oncotarget.28330.
7
Endometrial Cancer-Adjacent Tissues Express Higher Levels of Cancer-Promoting Genes than the Matched Tumors.子宫内膜癌旁组织表达的促癌基因水平高于相应肿瘤。
Genes (Basel). 2022 Sep 8;13(9):1611. doi: 10.3390/genes13091611.
8
Targeted immunotherapy against distinct cancer-associated fibroblasts overcomes treatment resistance in refractory HER2+ breast tumors.针对不同的癌相关成纤维细胞的靶向免疫疗法克服了难治性 HER2+ 乳腺癌肿瘤的治疗抵抗。
Nat Commun. 2022 Sep 9;13(1):5310. doi: 10.1038/s41467-022-32782-3.
9
Cancer-associated fibroblasts and resistance to anticancer therapies: status, mechanisms, and countermeasures.癌症相关成纤维细胞与抗癌治疗耐药性:现状、机制及对策
Cancer Cell Int. 2022 Apr 29;22(1):166. doi: 10.1186/s12935-022-02599-7.
10
JOINT AND INDIVIDUAL ANALYSIS OF BREAST CANCER HISTOLOGIC IMAGES AND GENOMIC COVARIATES.乳腺癌组织学图像与基因组协变量的联合及个体分析
Ann Appl Stat. 2021 Dec;15(4):1697-1722. doi: 10.1214/20-aoas1433. Epub 2021 Dec 21.
为什么我们没有患上更多的癌症?微环境在抑制癌症进展中起到的作用。
Nat Med. 2011 Mar;17(3):320-9. doi: 10.1038/nm.2328.
4
Building prognostic models for breast cancer patients using clinical variables and hundreds of gene expression signatures.利用临床变量和数百个基因表达特征为乳腺癌患者建立预后模型。
BMC Med Genomics. 2011 Jan 9;4:3. doi: 10.1186/1755-8794-4-3.
5
Microenvironmental influences that drive progression from benign breast disease to invasive breast cancer.推动良性乳腺疾病向浸润性乳腺癌进展的微环境影响。
J Mammary Gland Biol Neoplasia. 2010 Dec;15(4):389-97. doi: 10.1007/s10911-010-9195-8. Epub 2010 Dec 16.
6
Interactions with fibroblasts are distinct in Basal-like and luminal breast cancers.基底样和腔面型乳腺癌中与成纤维细胞的相互作用是不同的。
Mol Cancer Res. 2011 Jan;9(1):3-13. doi: 10.1158/1541-7786.MCR-10-0372. Epub 2010 Dec 3.
7
Markers of fibrosis and epithelial to mesenchymal transition demonstrate field cancerization in histologically normal tissue adjacent to breast tumors.纤维化和上皮间质转化的标志物在肿瘤旁组织中表现出癌化现象。
Int J Cancer. 2011 Sep 15;129(6):1310-21. doi: 10.1002/ijc.25788. Epub 2011 Feb 11.
8
Endogenous versus tumor-specific host response to breast carcinoma: a study of stromal response in synchronous breast primaries and biopsy site changes.内源性与肿瘤特异性宿主对乳腺癌的反应:同步原发性乳腺癌和活检部位变化中基质反应的研究。
Clin Cancer Res. 2011 Feb 1;17(3):437-46. doi: 10.1158/1078-0432.CCR-10-1709. Epub 2010 Nov 22.
9
Gene expression profiles of estrogen receptor-positive and estrogen receptor-negative breast cancers are detectable in histologically normal breast epithelium.雌激素受体阳性和雌激素受体阴性乳腺癌的基因表达谱可在组织学上正常的乳腺上皮中检测到。
Clin Cancer Res. 2011 Jan 15;17(2):236-46. doi: 10.1158/1078-0432.CCR-10-1369. Epub 2010 Nov 8.
10
Phenotypic and molecular characterization of the claudin-low intrinsic subtype of breast cancer.Claudin-low 型乳腺癌的表型和分子特征。
Breast Cancer Res. 2010;12(5):R68. doi: 10.1186/bcr2635. Epub 2010 Sep 2.